Bombay Oxygen Investments Ltd (BOMOXY-B1) — shareholding pattern, promoter holding, financials and share price
About Bombay Oxygen Investments Ltd (BOMOXY-B1)
Bombay Oxygen Investments Ltd operates in the Non Banking Financial Company (NBFC) industry, within the Financial Services sector. It trades on the NSE as BOMOXY-B1 and on the BSE under scrip code 509470. Its ISIN is INE01TL01014.
Incorporated in 1960, Bombay Oxygen Investments Ltd deals in financing and investments [1]
Bombay Oxygen Investment Limited, formerly Bombay Oxygen Corporation, operates as a Non-Banking Financial Company (NBFC) registered with the Reserve Bank of India. It primarily earns revenue from substantial financial investments in shares, mutual funds, and other securities.
The company, originally known for manufacturing industrial gases, ceased its production of industrial gases in August 2019, transitioning to focus on financial investments.
Listed peers in Non Banking Financial Company (NBFC): Ascom Leasing & Investments Ltd, Starteck Finance Ltd, Avonmore Capital & Management Services Ltd, Last Mile Enterprises Ltd, Sera Investments & Finance India Ltd, Vaarad Ventures Ltd.
Valuation & Returns
10 Jul 2026At ₹18,860.67 a share on 10 Jul 2026, Bombay Oxygen Investments Ltd (BOMOXY-B1) was valued at a price-to-earnings ratio of 108.39x against an industry P/E of 19.5x and a price-to-book of 0.59x on a book value of ₹32,204.87 per share as of Mar 2025. Solomo computes return on equity of 0.54% and return on capital employed of -0.82% from filed results. Earnings ratios use consolidated results for the twelve months Dec 2010 to Sep 2011.
- P/E
- 108.39x
- Industry P/E
- 19.5x
- P/B
- 0.59x
- EPS (TTM)
- ₹174
- Book value / share
- ₹32,204.87
- ROE
- 0.54%
- ROCE
- -0.82%
- ROA
- 0.51%
- Debt / equity
- 0x
- EBITDA margin
- 188.72%
- 52-week range
- ₹18,500.35 – ₹31,998
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2011In the year ended Mar 2011, Bombay Oxygen Investments Ltd (BOMOXY-B1) reported revenue of ₹41.74 crore, net profit of ₹4.15 crore and earnings per share of ₹276.67. That compares with revenue of ₹38.14 crore and net profit of ₹4.07 crore in Mar 2010. Figures are consolidated, as filed with the exchanges.
In the quarter ended Sep 2011, revenue was ₹9.79 crore and net profit ₹0.52 crore (consolidated).
| Metric | Mar 2009 | Mar 2010 | Mar 2011 |
|---|---|---|---|
| Revenue (₹ cr) | 32.51 | 38.14 | 41.74 |
| Net profit (₹ cr) | 0.59 | 4.07 | 4.15 |
| EPS (₹) | 39.33 | 271.33 | 276.67 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 1.58% | 98.35% | -15.37% | 9.44% |
| Profit growth | 52.99% | - | -14.56% | 1.97% |
| Stock price CAGR | 14% | 7% | 21% | -19% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 73.29% of Bombay Oxygen Investments Ltd (BOMOXY-B1) (unchanged from the previous quarter) and domestic institutional investors (DII) hold 0.06%. Market capitalisation was ₹283 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: Investor Education and Protection Fund (IEPF) 5.74%, Shubh Pharma Pvt Ltd 3.75%, LLP 1.77%, Sunvalue Trading Llp 1.48%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 73.29% | - | - | 0.06% | 26.71% |
| Mar 2026 | 73.29% | - | - | 0.06% | 26.71% |
| Dec 2025 | 73.29% | - | - | 0.06% | 26.71% |
| Sep 2025 | 73.29% | - | - | 0.06% | 26.71% |
| Jun 2025 | 73.29% | - | - | 0.06% | 26.71% |
| Mar 2025 | 73.29% | - | - | 0.06% | 26.71% |
| Dec 2024 | 73.29% | - | - | 0.06% | 26.71% |
| Sep 2024 | 72.96% | - | - | 0.06% | 27.04% |